Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

1.7K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Lowest PSA Level Achieved Before CRPC Predicts Abiraterone Response But Not Enzalutamide Response in Metastatic CRPC.

The Prostate·2026
Same author

Comparison of automated bone scan indexes in patients with prostate cancer: aBSI and BONENAVI.

Annals of nuclear medicine·2026
Same author

Efficacy of Testosterone Replacement Therapy Combined With Exercise on Body Composition in Hypogonadal Men.

International journal of urology : official journal of the Japanese Urological Association·2026
Same author

Prostate-Specific Membrane Antigen Positron Emission Tomography in Japan: An Implementation Gap in the Era of Global Adoption.

Asia-Pacific journal of clinical oncology·2026
Same author

Efficacy and Safety of Enzalutamide and Abiraterone in CRPC Patients With a History of Other Cancers: A Sub-Analysis of the ENABLE Study for PCa.

International journal of urology : official journal of the Japanese Urological Association·2026
Same author

Fibroblast-mediated KRAS activation in double-negative prostate cancer.

Cell death & disease·2026

Related Experiment Video

Updated: Mar 8, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

9.6K

Bone Microenvironment Changes in Latexin Expression Promote Chemoresistance.

Mi Zhang1,2, Mary Osisami1, Jinlu Dai1

  • 1Department of Urology, University of Michigan, Ann Arbor, Michigan.

Molecular Cancer Research : MCR
|January 15, 2017
PubMed
Summary

Latexin (LXN) loss promotes docetaxel resistance in prostate cancer. The bone microenvironment further enhances this resistance via methylation, suggesting LXN as a therapeutic target.

More Related Videos

Analyzing the Communication Between Monocytes and Primary Breast Cancer Cells in an Extracellular Matrix Extract ECME-based Three-dimensional System
10:55

Analyzing the Communication Between Monocytes and Primary Breast Cancer Cells in an Extracellular Matrix Extract ECME-based Three-dimensional System

Published on: January 8, 2018

11.6K
Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer
08:20

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer

Published on: May 21, 2019

6.1K

Related Experiment Videos

Last Updated: Mar 8, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

9.6K
Analyzing the Communication Between Monocytes and Primary Breast Cancer Cells in an Extracellular Matrix Extract ECME-based Three-dimensional System
10:55

Analyzing the Communication Between Monocytes and Primary Breast Cancer Cells in an Extracellular Matrix Extract ECME-based Three-dimensional System

Published on: January 8, 2018

11.6K
Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer
08:20

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer

Published on: May 21, 2019

6.1K

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Docetaxel is a standard treatment for advanced prostate cancer.
  • Acquired resistance to docetaxel limits treatment efficacy.
  • Understanding resistance mechanisms is crucial for improving therapy.

Purpose of the Study:

  • To investigate the role of latexin (LXN) in docetaxel resistance in prostate cancer.
  • To explore the influence of the bone microenvironment on chemoresistance.

Main Methods:

  • Comparative analysis of gene expression in docetaxel-sensitive and resistant prostate cancer cell lines.
  • In vitro and in vivo studies involving gene knockdown and overexpression.
  • Investigation of the bone microenvironment's effect on prostate cancer cells.

Main Results:

  • Decreased latexin (LXN) expression was observed in docetaxel-resistant prostate cancer cells.
  • LXN expression inversely correlated with taxane resistance.
  • Bone stromal cells induced LXN methylation and chemoresistance in prostate cancer cells.
  • The bone microenvironment was associated with decreased LXN expression and docetaxel resistance.

Conclusions:

  • Loss of LXN expression, driven by methylation in the bone microenvironment, contributes to docetaxel resistance in prostate cancer.
  • Targeting the LXN pathway may offer a strategy to overcome taxane resistance.